Alcon's UNITY VCS and CS win Edison Awards
The awards honor innovation in Health, Medical & Biotech. Recognition reflects team collaboration and dedication.
See the latest news and media coverage for Alcon. We track all announcements, press releases, and industry mentions in real time, all in one place.
Manufacturer of eye care products and surgical equipment
alcon.comLast updated
In short: Alcon reported a 10% revenue increase in Q1 2026, driven by new product launches and the acquisition of Aerie Pharmaceuticals.
The awards honor innovation in Health, Medical & Biotech. Recognition reflects team collaboration and dedication.
Sales reach $2.7 billion, up 10%; core EPS $0.85. New products like Unity and Tryptyr drive growth. $1.5B share repurchase authorized.
Shareholders approve all resolutions. R. Scott Herren elected to Board. Compensation and non-financial reports approved. Dividend of CHF 0.28 declared.
They exceeded targets, delivering 157,000+ vision screenings for children and cataract care to 5M+ people in low- and middle-income countries. New 2030 goals focus on systemic change.
Alcon stock sits between recent highs and lows while analysts keep mostly positive long-term views on the eye-care specialist. With no fresh corporate news today...
None...
A new class action lawsuit claims Alcon Laboratories falsely advertises its Systane eyedrops as being preservative-free when they actually contain boric acid.
The topics: DSM-Firmenich in Switzerland, sought-after AMS, news from Swatch Group, price turbulence over Alcon, and stoic Ermotti. The eye care company achieves a good quarter. That...
Track Alcon and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Alcon and other trending companies.